Peps
What is Melanotan II?
Melanotan II is an experimental melanocortin analogue studied for pigmentation. It is distinct from Melanotan I and other melanocortin medicines.
Biological role or research focus
Melanocortin-related pigmentation research.
Melanotan I and Melanotan II are different compounds. A seller listing of one is not a source for the other.
Role reference: Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. ↗
Names you may encounter
melanotan 2 · MT-2
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Cyclic melanocortin analogue
- Main research area
- Pigmentation research
- Evidence featured
- Human phase 1 pilot
- Source check
- October 4, 2026
Molecular structure
Mechanism & research rationale
Melanocortin-related signaling can affect pigmentation and other physiological responses. The early pilot showed that these effects were not restricted to skin color.
Research context & status
The pilot demonstrates an early pigmentation signal, not an established safe tanning intervention. It does not evaluate skin-cancer prevention or ultraviolet protection.
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Human phase 1 pilot · 1996
Early pigmentation study
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.
- Population / model
- Three healthy male volunteers.
- Study design
- Single-blind pilot with alternating saline and active exposure.
- Main finding
- Pigmentation increased in two participants. Nausea, fatigue/somnolence, and prolonged spontaneous erections were reported.
- Limits & context
- Three volunteers cannot establish uncommon risks or durable safety. Pigmentation is not evidence of protection against ultraviolet injury or skin cancer.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
Melanotan-II reverses memory impairment induced by a short-term HF diet. ↗
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023 Sep · Journal Article
Melanotan II User Experience: A Qualitative Study of Online Discussion Forums. ↗
Dermatology (Basel, Switzerland) · 2021 · Journal Article
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists. ↗
Journal of medicinal chemistry · 2022 Mar 10 · Journal Article, Research Support, Non-U.S. Gov't
Melanotan II overdose associated with priapism. ↗
Clinical toxicology (Philadelphia, Pa.) · 2013 May · Letter, Comment
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety evidence & remaining uncertainty
FDA cites serious adverse-event case reports. Nausea and prolonged erections also appeared in early research; tiny trials cannot establish uncommon-event risk.
Source: FDA · Peptide compounding safety concerns ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
2 matching video records · 0 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Biohackingturkey
Melanotan 2 (MT-2) Nedir? Mucize mi, Yoksa Tehlike mi? ↗
Title match · Captions not indexed
Dr. Trevor Bachmeyer
Melanotan 2 Masterclass (and a Huge List of Benefits) - Dr Trevor Bachmeyer ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
We have not added a supplier for this profile. Missing products and coded listings are not filled with guesses.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- What specific product, route, and research population does the claim refer to?
- Does the source measure an outcome in people, or only a laboratory marker?
- Melanotan I and Melanotan II are different compounds. A seller listing of one is not a source for the other.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Does a darker skin color demonstrate UV protection?
The cited trial did not establish that outcome.
Can a Melanotan I listing substitute for Melanotan II?
No. Different compounds need different identity and evidence checks.
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.
PUT THE EVIDENCE IN CONTEXT
Research guides
RESEARCH FIELD GUIDE
Melanotan I vs Melanotan II: one became a medicine, one did not
Melanotan I and Melanotan II were developed in the same lab to darken skin, but only Melanotan I (afamelanotide) became an approved medicine, for a rare light-sensitivity disease. Melanotan II has only tiny early studies and documented safety concerns.
Read the guide →